—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Immunitybio Inc (IBRX) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 36 out of 100 (momentum 38 · quality 24 · valuation 7), as of 2026-11-11.
  • Signal: Mixed moving-average stack — Trades -22.4% vs the 50-day and -15.3% vs the 200-day average, 45.7% below the 52-week high and +245.9% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: Immunitybio Inc trades 22.4% below its 50-day and 15.3% below its 200-day moving average. (as of 2026-11-10)

ImmunityBio is a biotechnology company that designs immunotherapies meant to activate the immune system against cancer and infectious disease. It develops several platforms, including engineered cytokine proteins, DNA-based vectors and cell therapies, aimed at solid and liquid tumours.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the IBRX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Mixed moving-average stack

Trades -22.4% vs the 50-day and -15.3% vs the 200-day average, 45.7% below the 52-week high and +245.9% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the IBRX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on IBRX?

Mixed moving-average stack — Trades -22.4% vs the 50-day and -15.3% vs the 200-day average, 45.7% below the 52-week high and +245.9% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is IBRX above its 50-day and 200-day moving averages?

As of 2026-11-10, Immunitybio Inc trades -22.4% below its 50-day and -15.3% below its 200-day average, with the 20-day -20.4% away.

How far is IBRX from its 52-week high?

45.7% below the 52-week high and 245.9% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.